As of June 21, 2025, Biostage Inc (BSTG) reports a Graham Number of 2.17.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Biostage Inc's Graham Number
Over recent years, Biostage Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 2.17 |
| 2021-12-31 | 2.17 |
| 2020-12-31 | 1.03 |
| 2019-12-31 | 1.33 |
| 2018-12-31 | 1.70 |
This slight downward trend highlights how Biostage Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Biostage Inc's Graham Number to Peers
To better understand Biostage Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Biostage Inc (BSTG) | 2.17 |
| AVAX Technologies Inc (AVXT) | 14.85 |
| Adhera Therapeutics Inc (ATRX) | 3.42 |
| Protalix Biotherapeutics Inc (PLX) | 0.67 |
| Immune Pharmaceuticals Inc (IMNPQ) | 0.45 |
| Sangui Biotech International Inc (SGBI) | 0.00 |
Compared to its competitors, Biostage Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.